Gyno-Pevaryl Depot

Gyno-Pevaryl Depot is a vaginal formulation that contains the antifungal agent econazole nitrate. It belongs to the imidazole class of antifungal drugs and is marketed in the European Union as a prescription product. The medication is intended for local treatment of fungal infections of the vagina, such as candidiasis, by delivering econazole nitrate directly to the affected area. It is used under physician guidance in practice.

Gyno-Pevaryl Depot is indicated for the treatment of fungal infections localized to the vagina.

- Management of acute vaginal candidiasis confirmed by clinical assessment. - Treatment of recurrent yeast infections of the vagina when topical therapy is preferred. - Adjunct therapy for mixed bacterial‑fungal vaginitis where an antifungal component is required. - Use in patients who cannot tolerate oral azole antifungals due to systemic side effects. - Prophylactic application after antibiotic therapy to reduce the risk of secondary yeast overgrowth. - Treatment of vulvovaginal yeast infection in patients with diabetes when localized therapy is indicated.

The safety profile of Gyno-Pevaryl Depot reflects the typical local tolerability of vaginal imidazole antifungals, with most adverse events being mild and reversible.

Common: - Mild vaginal irritation or burning sensation. - Transient itching or pruritus in the treated area. - Discharge with a slight odor that resolves after treatment. - Headache not directly related to the medication but reported by some users. - Mild abdominal cramping or pelvic discomfort during application. - Temporary increase in vaginal discharge volume.

Serious: - Allergic contact dermatitis presenting as redness, swelling, or rash. - Severe vulvar edema or ulceration. - Persistent or worsening vaginal symptoms suggesting secondary infection. - Rare systemic hypersensitivity reactions such as fever, chills, or malaise.

Precautions for Gyno-Pevaryl Depot focus on patient selection, proper administration technique, and monitoring for unexpected reactions.

- Confirm diagnosis of vaginal candidiasis before initiating therapy. - Avoid use in patients with known hypersensitivity to econazole or other imidazole antifungals. - Do not insert the product if the vaginal mucosa is severely inflamed, ulcerated, or bleeding. - Counsel patients to refrain from sexual intercourse or tampon use for a specified period after application. - Assess for diabetes or immunocompromised conditions that may affect treatment response. - Inform patients that the medication is for vaginal use only and should not be applied to other mucosal surfaces. - Store the product at room temperature, protected from moisture and direct sunlight.

Gyno-Pevaryl Depot may interact with other agents applied vaginally or systemic drugs that affect fungal flora.

Avoid: - Concurrent use of other intravaginal antifungal or antiseptic products, which may reduce efficacy or increase irritation. - Co‑administration with spermicidal agents that could alter mucosal absorption. - Use of vaginal douches or cleansing solutions during treatment, which can wash away the medication.

Use with caution: - Systemic azole antifungals (e.g., fluconazole) as combined therapy may increase risk of hepatic enzyme interactions. - Hormonal contraceptives delivered vaginally, as local irritation could affect absorption. - Topical corticosteroids in the vagina, which may mask signs of infection. - Patients receiving systemic immunosuppressants should be monitored, as fungal infections may progress despite topical therapy. - Patients receiving systemic azole antifungals should be monitored for additive hepatic effects.